Fosun Intl Delivers 1H26 Profit Rebound Despite Flat Revenue; Strengthens Balance Sheet and Streamlines Portfolio

Fosun International Limited (“Fosun Intl”) reported a sharp turnaround in profitability for the six months ended 30 June 2026, with profit attributable to shareholders surging 160.3% year-on-year to RMB1.72 billion, driven by a stronger showing in insurance and asset management. Basic and diluted EPS tripled to RMB0.21.

Revenue held broadly steady at RMB86.96 billion (-0.4% YoY). Overseas markets generated RMB49.16 billion, representing 56.5% of total revenue, up three percentage points from a year earlier.

Key segment performance: • Health revenue rose 6.5% to RMB24.03 billion; profit contribution dipped 4.5% to RMB0.72 billion. • Happiness revenue fell 6.2% to RMB31.63 billion; loss widened to RMB0.52 billion. • Wealth revenue slipped 1.9% to RMB27.31 billion, yet profit more than quintupled to RMB1.33 billion, buoyed by asset management’s return to profitability. • Insurance revenue grew 9.2% to RMB22.81 billion, delivering profit of RMB1.25 billion (+2.2%). • Intelligent Manufacturing revenue gained 14.6% to RMB4.61 billion; profit advanced 43.2% to RMB0.20 billion.

Total assets edged down 0.5% to RMB712.29 billion, while equity attributable to shareholders rose to RMB95.19 billion. Net gearing (total debt to total capital) improved to 55.7% from 57.1% at end-2025 as total debt fell to RMB218.31 billion and cash remained stable at RMB61.21 billion. Average financing cost decreased 30 basis points to 5.0%.

Industrial operation profit — the sum of operating results from core subsidiaries, associates and JVs — increased 17% YoY to RMB3.69 billion. Management reported cash proceeds of more than RMB12 billion from non-core asset disposals during the period and completed an early repayment of a USD530 million syndicated loan.

No interim dividend was declared. Fosun Intl repurchased 61.94 million shares on the Hong Kong Stock Exchange for HKD246.90 million between February and June 2026.

Looking ahead, the group will maintain its strategy of focusing on healthcare, consumption and insurance, continue to divest non-core assets, and seek further debt reduction while deepening global operations and advancing technology-driven upgrades.